Revolution Medicines, Inc. Shares (Diluted) increased by 4.7% to 198.1M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.3%, from 188.1M to 198.1M. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase indicates potential dilution from employee compensation or convertible instruments, which can reduce earnings per share.
The weighted-average number of common shares outstanding plus the effect of all potentially dilutive securities, such as...
Standard metric for all public companies; essential for understanding the impact of equity-based compensation.
weighted_shares_diluted| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 73.4M | 73.5M | 74.2M | 74.3M | 84.7M | 94.8M | 106.9M | 109.2M | 164.7M | 165.1M | 166.8M | 188.1M | 188.6M | 189.2M | 198.1M |
| QoQ Change | — | +0.2% | +0.9% | +0.2% | +14.0% | +12.0% | +12.7% | +2.2% | +50.8% | +0.3% | +1.0% | +12.8% | +0.2% | +0.3% | +4.7% |
| YoY Change | — | — | — | +1.2% | +15.2% | +27.9% | +43.9% | +29.0% | +73.7% | +54.5% | +52.7% | +14.2% | +14.2% | +13.4% | +5.3% |